Clinical trial

Biolinq External Interferent Protocol

NCT06560177

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-09-10

PhaseNA

Study timeline

Study start (actual)2024-09-10Date precision: day

Registry last updated2026-02-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitusunresolved

Interventions

The Biolinq MicroArray Intradermal Continuous Glucose Biowearable SystemDEVICE

Sponsors & collaborators

Biolinq Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06560177 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.